Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis

Ann Rheum Dis. 2020 Dec;79(12):e156. doi: 10.1136/annrheumdis-2019-215982. Epub 2019 Jul 12.

Authors

Shih-Wei Lai^{1

2}, Yu-Hung Kuo³, Kuan-Fu Liao^{4

5}

Affiliations

¹ College of Medicine, China Medical University, Taichung, Taiwan.
² Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
³ Department of Research, Taichung Tzu Chi Hospital, Taichung, Taiwan.
⁴ College of Medicine, Tzu Chi University, Hualien, Taiwan kuanfuliaog@gmail.com.
⁵ Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan.

PMID: 31300456
DOI: 10.1136/annrheumdis-2019-215982

No abstract available

Keywords: rheumatoid arthritis.

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid* / drug therapy
Fractures, Bone* / chemically induced
Fractures, Bone* / epidemiology
Humans
Proton Pump Inhibitors / adverse effects

Substances

Proton Pump Inhibitors